These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 15292904)

  • 1. Serotonin and dopamine transporter availabilities correlate with the loudness dependence of auditory evoked potentials in patients with obsessive-compulsive disorder.
    Pogarell O; Tatsch K; Juckel G; Hamann C; Mulert C; Pöpperl G; Folkerts M; Choukèr M; Riedel M; Zaudig M; Möller HJ; Hegerl U
    Neuropsychopharmacology; 2004 Oct; 29(10):1910-7. PubMed ID: 15292904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced dopamine transporter density in psychotropic-naive patients with obsessive-compulsive disorder shown by [123I]{beta}-CIT SPECT.
    van der Wee NJ; Stevens H; Hardeman JA; Mandl RC; Denys DA; van Megen HJ; Kahn RS; Westenberg HM
    Am J Psychiatry; 2004 Dec; 161(12):2201-6. PubMed ID: 15569890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine transporter density of basal ganglia assessed with [123I]IPT SPET in obsessive-compulsive disorder.
    Kim CH; Koo MS; Cheon KA; Ryu YH; Lee JD; Lee HS
    Eur J Nucl Med Mol Imaging; 2003 Dec; 30(12):1637-43. PubMed ID: 14513291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin and dopamine transporter imaging in patients with obsessive-compulsive disorder.
    Hesse S; Müller U; Lincke T; Barthel H; Villmann T; Angermeyer MC; Sabri O; Stengler-Wenzke K
    Psychiatry Res; 2005 Oct; 140(1):63-72. PubMed ID: 16213689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [123I] ADAM brainstem binding correlates with the loudness dependence of auditory evoked potentials.
    Pogarell O; Koch W; Schaaff N; Pöpperl G; Mulert C; Juckel G; Möller HJ; Hegerl U; Tatsch K
    Eur Arch Psychiatry Clin Neurosci; 2008 Feb; 258(1):40-7. PubMed ID: 17990053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated brain serotonin transporter availability in patients with obsessive-compulsive disorder.
    Pogarell O; Hamann C; Pöpperl G; Juckel G; Choukèr M; Zaudig M; Riedel M; Möller HJ; Hegerl U; Tatsch K
    Biol Psychiatry; 2003 Dec; 54(12):1406-13. PubMed ID: 14675805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new model for separation between brain dopamine and serotonin transporters in 123I-beta-CIT SPECT measurements: normal values and sex and age dependence.
    Ryding E; Lindström M; Brådvik B; Grabowski M; Bosson P; Träskman-Bendz L; Rosén I
    Eur J Nucl Med Mol Imaging; 2004 Aug; 31(8):1114-8. PubMed ID: 15014902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered serotonin and dopamine transporter availabilities in brain of depressed patients upon treatment with escitalopram: A [123 I]β-CIT SPECT study.
    Rominger A; Cumming P; Brendel M; Xiong G; Zach C; Karch S; Tatsch K; Bartenstein P; la Fougère C; Koch W; Pogarell O
    Eur Neuropsychopharmacol; 2015 Jun; 25(6):873-81. PubMed ID: 25819144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging serotonin and dopamine transporters with 123I-beta-CIT SPECT: binding kinetics and effects of normal aging.
    Pirker W; Asenbaum S; Hauk M; Kandlhofer S; Tauscher J; Willeit M; Neumeister A; Praschak-Rieder N; Angelberger P; Brücke T
    J Nucl Med; 2000 Jan; 41(1):36-44. PubMed ID: 10647603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [[123I]beta-CIT SPECT imaging of dopamine and serotonin transporters in Parkinson's disease and multiple system atrophy.
    Berding G; Brücke T; Odin P; Brooks DJ; Kolbe H; Gielow P; Harke H; Knoop BO; Dengler R; Knapp WH
    Nuklearmedizin; 2003 Feb; 42(1):31-8. PubMed ID: 12601452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin transporter binding in Tourette Syndrome.
    Müller-Vahl KR; Meyer GJ; Knapp WH; Emrich HM; Gielow P; Brücke T; Berding G
    Neurosci Lett; 2005 Sep; 385(2):120-5. PubMed ID: 15936877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced serotonin transporter-availability in obsessive-compulsive disorder (OCD).
    Stengler-Wenzke K; Müller U; Angermeyer MC; Sabri O; Hesse S
    Eur Arch Psychiatry Clin Neurosci; 2004 Aug; 254(4):252-5. PubMed ID: 15309396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SERT and DAT availabilities under citalopram treatment in obsessive-compulsive disorder (OCD).
    Pogarell O; Poepperl G; Mulert C; Hamann C; Sadowsky N; Riedel M; Moeller HJ; Hegerl U; Tatsch K
    Eur Neuropsychopharmacol; 2005 Oct; 15(5):521-4. PubMed ID: 16139170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loudness dependence of auditory evoked potentials (LDAEP) correlates with the availability of dopamine transporters and serotonin transporters in healthy volunteers-a two isotopes SPECT study.
    Lee IH; Yang YK; Chen PS; Huang HC; Yeh TL; Lu RB; Chiu NT; Yao WJ; Lin SH
    Psychopharmacology (Berl); 2011 Apr; 214(3):617-24. PubMed ID: 21072504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin 2A receptor, serotonin transporter and dopamine transporter alterations in dogs with compulsive behaviour as a promising model for human obsessive-compulsive disorder.
    Vermeire S; Audenaert K; De Meester R; Vandermeulen E; Waelbers T; De Spiegeleer B; Eersels J; Dobbeleir A; Peremans K
    Psychiatry Res; 2012 Jan; 201(1):78-87. PubMed ID: 22285716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of rs591323 on serotonin transporter availability in healthy male subjects.
    Pak K; Nam HY; Shin S; Kim K; Lee MJ; Kim EJ; Lee JM; Kim SJ; Kim IJ
    Ann Nucl Med; 2018 Aug; 32(7):431-436. PubMed ID: 29774458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex differences in [123I]beta-CIT SPECT measures of dopamine and serotonin transporter availability in healthy smokers and nonsmokers.
    Staley JK; Krishnan-Sarin S; Zoghbi S; Tamagnan G; Fujita M; Seibyl JP; Maciejewski PK; O'Malley S; Innis RB
    Synapse; 2001 Sep; 41(4):275-84. PubMed ID: 11494398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Voxel-wise analysis of [123I]beta-CIT SPECT differentiates the Parkinson variant of multiple system atrophy from idiopathic Parkinson's disease.
    Scherfler C; Seppi K; Donnemiller E; Goebel G; Brenneis C; Virgolini I; Wenning GK; Poewe W
    Brain; 2005 Jul; 128(Pt 7):1605-12. PubMed ID: 15817519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients.
    Seibyl JP; Marek K; Sheff K; Zoghbi S; Baldwin RM; Charney DS; van Dyck CH; Innis RB
    J Nucl Med; 1998 Sep; 39(9):1500-8. PubMed ID: 9744331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine transporter density of the basal ganglia assessed with [123I]IPT SPECT in drug-naive children with Tourette's disorder.
    Cheon KA; Ryu YH; Namkoong K; Kim CH; Kim JJ; Lee JD
    Psychiatry Res; 2004 Jan; 130(1):85-95. PubMed ID: 14972371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.